SO-4 phase Ib/II, open-label, randomised evaluation of atezolizumab plus RO6874281 vs control in MORPHEUS–pancreatic ductal adenocarcinoma
| Autor: | Chung, V., Alistar, A., George, B., Kim, K., Kindler, H., Oh, D., Allen, S., Barak, H., Ci, B., Lau, J., Retiere, A., Shemesh, C., Teichgräber, V., Zhang, X., Lopez, C. |
|---|---|
| Zdroj: | In Annals of Oncology July 2020 31 Supplement 3:S218-S218 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|